About Luke Evnin
Luke Evnin is a 10% owner at Entrada Therapeutics.
Form D filings name Luke Evnin as a director at Redona Therapeutics.
Luke Evnin reports to the SEC as a director, officer or major shareholder of 47 public companies, including Werewolf Therapeutics (HOWL), Aktis Oncology (AKTS) and iTeos Therapeutics (ITOS).
Luke Evnin first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Luke Evnin in the role, so the role may have started earlier or lasted longer.
EI
Entrada Therapeutics, Inc.
10% owner
2021 – 2026 · Public company (TRDA)
WI
Werewolf Therapeutics, Inc.
Director and 10% owner
2021 – 2026 · Public company (HOWL)
AI
II
iTeos Therapeutics, Inc.
10% owner
2020 – 2025 · Public company (ITOS)
TI
TCR2 Therapeutics Inc.
10% owner
2019 – 2023 · Public company (TCRR)
OI
Oncorus, Inc.
Director and 10% owner
2020 – 2022 · Public company (ONCR)
TC
Turmeric Acquisition Corp.
Chief Executive Officer
2020 – 2021 · Public company (TMPM)
HI
Harpoon Therapeutics, Inc.
Director and 10% owner
2019 – 2021 · Public company (HARP)
DI
Dyne Therapeutics, Inc.
10% owner
2020 · Public company (DYN)
RI
Repare Therapeutics Inc.
10% owner
2020 · Public company (RPTX)
SI
Syndax Pharmaceuticals Inc
Director and 10% owner
2016 – 2018 · Public company (SNDX)
RI
Rhythm Pharmaceuticals, Inc.
10% owner
2017 · Public company (RYTM)
RI
Radius Health, Inc.
10% owner
2008 – 2016 · Public company (RDUS)
AI
Avalo Therapeutics, Inc.
10% owner
2015 · Public company (AVTX)
CI
Chiasma, Inc.
10% owner
2015 · Public company (CHMA)
RI
ReShape Weightloss Inc.
Director and 10% owner
2007 – 2014 · Public company (RSLS)
TI
TriVascular Technologies, Inc.
10% owner
2014 · Public company (TRIV)
AI
Aratana Therapeutics, Inc.
10% owner
2013 – 2014 · Public company (PETX)
EI
Epizyme, Inc.
10% owner
2013 – 2014 · Public company (EPZM)
HI
Histogen Inc.
10% owner
2013 · Public company (HSTO)
PI
Pacira BioSciences, Inc.
Director and 10% owner
2011 – 2013 · Public company (PCRX)
HI
Humanigen, Inc.
10% owner
2012 – 2013 · Public company (HGEN)
PI
Pernix Sleep, Inc.
10% owner
2007 – 2012 · Public company (SOMX)
VI
Verastem, Inc.
Reporting person
2012 · Public company (VSTM)
EI
EPIRUS Biopharmaceuticals, Inc.
10% owner
2009 – 2011 · Public company (EPRS)
AI
Altimmune, Inc.
10% owner
2007 – 2010 · Public company (ALT)
AI
ARYx Therapeutics, Inc.
10% owner
2007 – 2010 · Public company (ARYX)
SI
Senorx Inc.
10% owner
2007 – 2010 · Public company (SENO)
AI
Aveo Pharmaceuticals, Inc.
10% owner
2010 · Public company (AVEO)
MI
Metabasis Therapeutics Inc.
Director and 10% owner
2006 – 2010 · Public company (MBRX)
PI
Peplin Inc.
10% owner
2008 – 2009 · Public company (PLIN)
PI
Poniard Pharmaceuticals, Inc.
10% owner
2006 – 2009 · Public company (PARD)
OC
Oscient Pharmaceuticals Corp.
Director and 10% owner
2006 – 2009 · Public company (OSCI)
MC
Memory Pharmaceuticals Corp.
10% owner
2006 – 2009 · Public company (MEMY)
RI
Restore Medical, Inc.
Director and 10% owner
2006 – 2008 · Public company (REST)
PI
Pharmasset Inc
10% owner
2007 – 2008 · Public company (VRUS)
CI
Cryocor Inc.
10% owner
2007 – 2008 · Public company (CRYO)
VI
Viacell Inc.
10% owner
2007 · Public company (VIAC)
HI
Hemosense Inc.
10% owner
2007 · Public company (HEM)
AC
Alsius Corp
10% owner
2007 · Public company (ALUS)
HC
Helicos Biosciences Corp.
10% owner
2007 · Public company (HLCS)
TI
T-Mobile US, Inc.
10% owner
2007 · Public company (TMUS)
CI
Cornerstone Therapeutics Inc.
Reporting person
2007 · Public company (CRTX)
CI
Cotherix Inc.
10% owner
2007 · Public company (CTRX)
AI
Affymax Inc.
10% owner
2006 · Public company (AFFY)
OI
Omrix Biopharmaceuticals, Inc.
10% owner
2006 · Public company (OMRI)
AI
Acorda Therapeutics, Inc.
10% owner
2006 · Public company (ACOR)
Key Colleagues at Startups
The people Luke Evnin works with at each company, as listed on that company's latest Form D.
Redona Therapeutics, Inc. · Form D, Jul 31, 2023
MS
Michal Silverberg
Director
KS
Kazumi Shiosaki
President and Chief Executive Officer, director
HR
Henrijette Richter
Director
CB
Christine Brennan
Director